Details

Autor(en) / Beteiligte

• Thiele, Susanne
• Werner, Ralf
• Grötzinger, Joachim
• Brix, Bettina
• Staedt, Pia
• Struve, Dagmar
• Reiz, Benedikt
• Farida, Jennane
• Hiort, Olaf

Titel

A positive genotype–phenotype correlation in a large cohort of patients with Pseudohypoparathyroidism Type Ia and Pseudo‐pseudohypoparathyroidism and 33 newly identified mutations in the GNAS gene

Ist Teil von

• Molecular genetics & genomic medicine, 2015-03, Vol.3 (2), p.111-120

Ort / Verlag

United States: John Wiley & Sons, Inc

Erscheinungsjahr

2015

Quelle

Elektronische Zeitschriftenbibliothek (Open access)

Beschreibungen/Notizen

• Maternally inherited inactivating GNAS mutations are the most common cause of parathyroid hormone (PTH) resistance and Albright hereditary osteodystrophy (AHO) leading to pseudohypoparathyroidism type Ia (PHPIa) due to Gsα deficiency. Paternally inherited inactivating mutations lead to isolated AHO signs characterizing pseudo‐pseudohypoparathyroidism (PPHP). Mutations are distributed throughout the Gsα coding exons of GNAS and there is a lack of genotype–phenotype correlation. In this study, we sequenced exon 1–13 of GNAS in a large cohort of PHPIa‐ and PPHP patients and identified 58 different mutations in 88 patients and 27 relatives. Thirty‐three mutations including 15 missense mutations were newly discovered. Furthermore, we found three hot spots: a known hotspot (p.D190MfsX14), a second at codon 166 (p.R166C), and a third at the exon 5 acceptor splice site (c.435 + 1G>A), found in 15, 5, and 4 unrelated patients, respectively. Comparing the clinical features to the molecular genetic data, a significantly higher occurrence of subcutaneous calcifications in patients harboring truncating versus missense mutations was demonstrated. Thus, in the largest cohort of PHPIa patients described to date, we extend the spectrum of known GNAS mutations and hot spots and demonstrate for the first time a correlation between the genetic defects and the expression of a clinical AHO‐feature. In this study, we sequenced exon 1–13 of GNAS in the largest cohort of pseudohypoparathyroidism type Ia (PHPIa)‐ and pseudo‐pseudohypoparathyroidism (PPHP) patients described to date and identified 58 different mutations, of whom 33 have not been described before. Furthermore, we demonstrate for the first time two genotype–phenotype correlations in PHPIa patients harboring truncating versus missense mutations.